Physician profile
Kelly Dawson
NPI 1609413319
$39,662.75
in general payments reported to CMS, 2019-2025
6 companies · $1,035 in 2025
The $1,035 reported for 2025 was more than what 97% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,235 · 2022: $8,057 · 2023: $11K · 2024: $13K · 2025: $1,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $12K · Food and Beverage: $1,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,465.00 |
| Travel and Lodging | $11,833.48 |
| Food and Beverage | $1,072.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk As | $23,437.50 | 2021-2025 | Novoseven |
| Genentech USA, INC. | $10,297.82 | 2021-2023 | Hemlibra |
| Octapharma USA, INC. | $2,892.31 | 2022 | |
| Genzyme Corporation | $2,833.08 | 2023 | |
| Novo Nordisk INC | $102.04 | 2023 | Novoseven |
| Pfizer INC. | $100.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Dawson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.